Interleukin-17D mediates tumor rejection through recruitment of natural killer cells
about
Th17 cells in autoimmune and infectious diseasesThe roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunityTargeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer TypeTrial Watch-Immunostimulation with cytokines in cancer therapyFrom mice to humans: developments in cancer immunoeditingNrf2 Induces IL-17D to Mediate Tumor and Virus SurveillanceThe ancient cytokine IL-17D is regulated by Nrf2 and mediates tumor and virus surveillanceMechanisms and applications of interleukins in cancer immunotherapy.Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCVCharacterization of Lamprey IL-17 Family Members and Their Receptors.Cytokine profile of breast cell lines after different radiation doses.Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications.Tumor-expressed IL-17D recruits NK cells to reject tumors.Innate sensing of cancer's non-immunologic hallmarks.Immunosurveillance and immunoediting in MMTV-PyMT-induced mammary oncogenesis.A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts.Probabilistic prioritization of candidate pathway association with pathway scoreInterleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection
P2860
Q21284677-0090F509-A0D7-443B-A74A-2BB7954614BAQ26750673-047E86CD-F919-41B4-BD48-194778496AF1Q28066522-1788FFC0-2A3E-4EDF-A361-E6C20BF2CC6BQ28078725-6D1003E5-AA31-4922-9DF0-F8BC710D25CAQ28088304-A9B29E38-C64A-4EFA-B3A3-9F91407944E7Q28388093-DF764B32-CFB7-48AD-9314-E6A80FBE2AE9Q29247987-86E3EF21-85AF-4AFE-819C-4768AF23CD5CQ34458290-C9C7425C-1582-40F1-A7D4-A4075E8ABC30Q36201371-3600E4D2-6CD0-4C29-9887-112BC590D1F7Q36304936-08D9A9B5-CFFB-41E1-8AEE-925E626505C9Q38649440-8848852F-7114-48A5-82CD-4398CC48469FQ39376982-3100142A-0313-4F2C-A289-1AA4972C8A34Q42127910-BE23DA9C-D55E-4D79-8068-2167FFD1B5EAQ46065433-1A12D343-5ABE-42FD-A303-125469207BA8Q46511830-CCA9B820-D52B-4D66-9638-FB22A57D7906Q48023237-E5C69C19-D953-464D-BFFA-92B4758655F4Q52651816-FFDBF98A-78BB-4FAE-A46E-075F819582ADQ57790153-E4E3500F-1E82-4CA7-BBDE-984BD872DCE1Q58747372-90DE44AB-A73A-408B-AAC2-CFB535FC033A
P2860
Interleukin-17D mediates tumor rejection through recruitment of natural killer cells
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Interleukin-17D mediates tumor rejection through recruitment of natural killer cells
@en
type
label
Interleukin-17D mediates tumor rejection through recruitment of natural killer cells
@en
prefLabel
Interleukin-17D mediates tumor rejection through recruitment of natural killer cells
@en
P2093
P2860
P1433
P1476
Interleukin-17D mediates tumor rejection through recruitment of natural killer cells
@en
P2093
Emilie Gross
Hiroaki Ikeda
Jack D Bui
Miller Tran
Stephen P Mayfield
P2860
P304
P356
10.1016/J.CELREP.2014.03.073
P577
2014-05-01T00:00:00Z